Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lung airspace (ventilation assessment) refers to the evaluation of how effectively air moves in and out of the alveolar spaces within the lungs. This is a physiological parameter assessed through various clinical and imaging techniques to determine regional or global lung ventilation. It is crucial for diagnosing pulmonary embolism (via V/Q scan), evaluating chronic obstructive pulmonary disease (COPD), asthma, pneumonia, ARDS, preoperative risk stratification, and monitoring response to therapy in respiratory diseases.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lung Airspace (Ventilation Assessment) (None).